[go: up one dir, main page]

ES2144513T3 - Inhibicion de crecimiento tumoral inducido por traumatismo. - Google Patents

Inhibicion de crecimiento tumoral inducido por traumatismo.

Info

Publication number
ES2144513T3
ES2144513T3 ES94908743T ES94908743T ES2144513T3 ES 2144513 T3 ES2144513 T3 ES 2144513T3 ES 94908743 T ES94908743 T ES 94908743T ES 94908743 T ES94908743 T ES 94908743T ES 2144513 T3 ES2144513 T3 ES 2144513T3
Authority
ES
Spain
Prior art keywords
trauma
inhibition
tumor growth
growth induced
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94908743T
Other languages
English (en)
Inventor
Arthur E Bodgen
Jacques-Pierre Moreau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Bioscience Inc
Original Assignee
Ipsen Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Bioscience Inc filed Critical Ipsen Bioscience Inc
Application granted granted Critical
Publication of ES2144513T3 publication Critical patent/ES2144513T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN METODO PARA INHIBIR EN UN MAMIFERO EL CRECIMIENTO ACELERADO DE UN TUMOR SOLIDO O PRIMARIO METASTICO RESULTANTE DEL TRAUMA POR TEJIDO ORIGINADO QUIRURGICAMENTE, NO QUIRURGICAMENTE, O POR ULCERACION DE TEJIDO, CUYO METODO COMPRENDE EL PASO DE ADMINISTRAR AL MAMIFERO UNA CANTIDAD EFECTIVA TERAPEUTICAMENTE DE SOMATOSTATINA O UN AGONISTA DE SOMATOSTATINA.
ES94908743T 1993-02-11 1994-02-08 Inhibicion de crecimiento tumoral inducido por traumatismo. Expired - Lifetime ES2144513T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/016,720 US5504069A (en) 1993-02-11 1993-02-11 Inhibition of trauma-induced tumor growth

Publications (1)

Publication Number Publication Date
ES2144513T3 true ES2144513T3 (es) 2000-06-16

Family

ID=21778603

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94908743T Expired - Lifetime ES2144513T3 (es) 1993-02-11 1994-02-08 Inhibicion de crecimiento tumoral inducido por traumatismo.

Country Status (12)

Country Link
US (1) US5504069A (es)
EP (1) EP0644893B1 (es)
AT (1) ATE191919T1 (es)
AU (1) AU6172294A (es)
CA (1) CA2133557A1 (es)
DE (1) DE69424008T2 (es)
DK (1) DK0644893T3 (es)
ES (1) ES2144513T3 (es)
GR (1) GR3033968T3 (es)
PT (1) PT644893E (es)
WO (1) WO1994018231A1 (es)
ZA (1) ZA94960B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701952B1 (fr) * 1993-02-22 1995-03-31 Adir Nouveaux dérivés cyclopeptidiques de l'angiopeptine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
CA2319252C (en) * 1998-01-21 2004-11-30 Brigham And Women's Hospital, Inc. Circulating insulin-like growth factor-i and prostate cancer risk
AUPP221098A0 (en) * 1998-03-06 1998-04-02 Diatech Pty Ltd V-like domain binding molecules
US6150333A (en) * 1998-07-30 2000-11-21 Biomeasure, Inc. Methods of using a somatostatin analogue
IT1302289B1 (it) * 1998-09-30 2000-09-05 Univ Catania Composizioni farmaceutiche ad attivita' antineoplastica
RU2156137C1 (ru) * 1999-10-05 2000-09-20 Центральный научно-исследовательский рентгено-радиологический институт МЗ России Способ лечения злокачественных опухолей поджелудочной железы
WO2002081499A2 (en) * 2001-04-09 2002-10-17 The Administrators Of The Tulane Educational Fund Somatostatin agonists

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4133782A (en) * 1976-06-07 1979-01-09 The Salk Institute For Biological Studies Somatostatin analogs with dissociated biological activities
DE2860734D1 (en) * 1977-06-08 1981-09-03 Merck & Co Inc Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity
US4316890A (en) * 1979-03-16 1982-02-23 Ciba-Geigy Corporation Peptides and processes for the manufacture thereof
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
EP0031303A3 (de) * 1979-12-21 1981-11-04 Ciba-Geigy Ag Cyclooctapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
ATE14226T1 (de) * 1981-12-24 1985-07-15 Ciba Geigy Ag Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
US4486415A (en) * 1983-08-15 1984-12-04 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
NO893088L (no) * 1988-08-18 1990-02-19 Syntex Inc Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds

Also Published As

Publication number Publication date
EP0644893A1 (en) 1995-03-29
DK0644893T3 (da) 2000-07-17
DE69424008T2 (de) 2000-09-28
EP0644893B1 (en) 2000-04-19
GR3033968T3 (en) 2000-11-30
AU6172294A (en) 1994-08-29
WO1994018231A1 (en) 1994-08-18
ATE191919T1 (de) 2000-05-15
DE69424008D1 (de) 2000-05-25
EP0644893A4 (en) 1995-09-20
US5504069A (en) 1996-04-02
PT644893E (pt) 2000-07-31
CA2133557A1 (en) 1994-08-18
ZA94960B (en) 1994-08-23

Similar Documents

Publication Publication Date Title
EP0342541A3 (en) Retroviral protease inhibitors
MX9707192A (es) Compuestos triciclicos de carbamato, utiles para la inhibicion de la funcion de la proteina g y paratratamiento de enfermedades proliferativas.
NO20003018L (no) Triazinangiogenese-inhibitorer
TR200200082T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
BG102259A (en) Compostions with controlled paroxetine release
DK0768885T3 (da) Fremgangsmåde til inhibering af cancermetastase ved oral administration af oplöselig modificeret citruspectin
DE60045426D1 (de) Phenyl-benzyl-ketone
FI974368A0 (fi) Kasvuhormonin vapautumista edistäviä dipeptidejä
BG101712A (en) Method for cathepsin k inhibition
BG104779A (en) Inhibitors of phospholipase enzymes
BR9811099A (pt) Inibidores de urocinase
EP1106179A3 (en) Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
EP1586558A3 (en) Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
NO942641L (no) Inhibisjon av fosfatidylinositol 3-kinase med wortmannin og analoger derav
GR3035774T3 (en) Substituted benzolactam compounds as substance p antagonists
AU7607991A (en) Method of inhibiting gastric acid secretion
CO5261493A1 (es) Procedimiento y compuestos para la inhibicion de la mrp1
TR200102515T2 (tr) Egzersiz kaynaklı astma tedavisi için metod.
BG101875A (en) New cryptoficins and method for their preparation
ES2144513T3 (es) Inhibicion de crecimiento tumoral inducido por traumatismo.
ES2110115T3 (es) Inhibidores de la agregacion de plaquetas.
EP0943620A3 (en) Betulinic acid derivatives for inhibiting cancer growth
WO2000029012A8 (en) Methods of alleviating cancer symptoms
ES8703141A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirazol.
BR0114677A (pt) Inibição da dependência de fator de crescimento de células de tumores

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 644893

Country of ref document: ES